These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3542342)
21. Metabolic and hormonal effects of preferential beta 1 and beta 2-adrenoceptor stimulation in man. Tantucci C; Santeusanio F; Beschi M; Castellano M; Sorbini C; Grassi V J Endocrinol Invest; 1988 Apr; 11(4):279-87. PubMed ID: 2842389 [TBL] [Abstract][Full Text] [Related]
22. Electrocardiographic changes induced by inhaled salbutamol after treatment with bendrofluazide: effects of replacement therapy with potassium, magnesium and triamterene. Lipworth BJ; McDevitt DG; Struthers AD Clin Sci (Lond); 1990 Mar; 78(3):255-9. PubMed ID: 2156644 [TBL] [Abstract][Full Text] [Related]
23. Intracellular pH and electrolytes in human skeletal muscle during adrenaline and insulin infusions. Sahlin K; Henriksson J; Juhlin-Dannfelt A Clin Sci (Lond); 1984 Oct; 67(4):461-4. PubMed ID: 6380895 [TBL] [Abstract][Full Text] [Related]
24. Factor-VIII activity and antigen, platelet count and biochemical changes after adrenoceptor stimulation. Ingram GI; Jones RV; Hershgold EJ; Denson KW; Perkins JR Br J Haematol; 1977 Jan; 35(1):81-100. PubMed ID: 869996 [TBL] [Abstract][Full Text] [Related]
25. Transient insulin resistance following infusion of adrenaline in type 1 (insulin-dependent) diabetes mellitus. Kollind M; Adamson U; Lins PE; Hamberger B Diabetologia; 1988 Aug; 31(8):603-6. PubMed ID: 2906021 [TBL] [Abstract][Full Text] [Related]
26. The metabolic actions of intravenous salbutamol and aminophylline singly and in combination. Jenkins CR; Marlin GE Br J Clin Pharmacol; 1981 Feb; 11(2):197-201. PubMed ID: 7011349 [TBL] [Abstract][Full Text] [Related]
27. Effects of circulating endogenous catecholamines on plasma glucose, potassium and magnesium. Corr LA; Grounds RM; Beacham JL; Whitwam JG; Brown MJ Clin Sci (Lond); 1990 Feb; 78(2):185-91. PubMed ID: 2155747 [TBL] [Abstract][Full Text] [Related]
28. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia. Rizza RA; Cryer PE; Gerich JE J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413 [TBL] [Abstract][Full Text] [Related]
29. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects. Ferro A; Hall JA; Dickerson JE; Brown MJ Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585 [TBL] [Abstract][Full Text] [Related]
30. Is there a need to treat hypokalaemia associated with intravenous salbutamol infusion? Chua S; Razvi K; Wong MT; Tay R; Arulkumaran S J Obstet Gynaecol Res; 1997 Aug; 23(4):381-7. PubMed ID: 9311181 [TBL] [Abstract][Full Text] [Related]
31. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin. Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542 [TBL] [Abstract][Full Text] [Related]
32. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man--a comparison with the effect of adrenaline. Attvall S; Fowelin J; von Schenck H; Smith U; Lager I J Clin Endocrinol Metab; 1992 May; 74(5):1110-5. PubMed ID: 1569157 [TBL] [Abstract][Full Text] [Related]
33. Metabolic effects of salbutamol infusion during premature labour. Thomas DJ; Dove AF; Alberti KG Br J Obstet Gynaecol; 1977 Jul; 84(7):497-99. PubMed ID: 911704 [TBL] [Abstract][Full Text] [Related]
34. The relationship between some beta-adrenergic mediated responses and plasma concentrations of adrenaline and cyclic AMP in man. Philipsen EK; Myhre J; Larsen S; Damkjaer Nielsen M; Holst JJ; Hilsted J Acta Endocrinol (Copenh); 1990 Jan; 122(1):115-20. PubMed ID: 1968306 [TBL] [Abstract][Full Text] [Related]
35. Effect of alpha-adrenergic stimulation and its blockade on glucose turnover in man. Rizza RA; Haymond MW; Miles JM; Verdonk CA; Cryer PE; Gerich JE Am J Physiol; 1980 May; 238(5):E467-72. PubMed ID: 6990786 [TBL] [Abstract][Full Text] [Related]
36. Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline. Whyte KF; De Vane PJ; Whitesmith R; Kelman A; Reid JL Br J Clin Pharmacol; 1989 May; 27(5):553-61. PubMed ID: 2569322 [TBL] [Abstract][Full Text] [Related]
38. The effect of adrenaline upon cardiovascular and metabolic functions in man. Fellows IW; Bennett T; MacDonald IA Clin Sci (Lond); 1985 Aug; 69(2):215-22. PubMed ID: 4064565 [TBL] [Abstract][Full Text] [Related]
39. Catecholamine modulation of magnesium plasma levels in the rat. Guideri G Arch Int Pharmacodyn Ther; 1992; 320():103-14. PubMed ID: 1363770 [TBL] [Abstract][Full Text] [Related]
40. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]